Arkolith/Insider Trading/TCRR/Form 4

Sullivan Eric

Chief Financial OfficerTCR2 THERAPEUTICS INC. (TCRR) · full profile →Form 4 · filed Jun 1, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
0 non-derivative · 3 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 1, 2023Disposed to issuer(D)250K—$00
Jun 1, 2023Disposed to issuer(D)7K—$00
Jun 1, 2023Disposed to issuer(D)41K—$00

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-23-067075) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML